CRISPR Therapeutics AG (CRSP) stock forecast and price target · CRSPCRISPR Therapeutics AG. (%). At close: PM · Recommendation Rating. Is CRISPR Therapeutics AG stock A Buy? CRISPR Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will. On Friday 06/28/ the closing price of the CRISPR Therapeutics AG share was $ on BTT. CRISPR Therapeutics AG (CRSP) stock price prediction is USD. The CRISPR Therapeutics AG stock forecast is USD for June. On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $ by Jun 17, The average Crispr Therapeutics Ag stock.

CRISPR Therapeutics AG has a consensus price target of $, established from looking at the latest analyst ratings. The last 3 analyst ratings were. According to the latest long-term forecast, CRISPR Therapeutics price will hit $65 by the end of and then $ by the end of CRISPR Therapeutics will. CRISPR Therapeutics AG ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - What is CRISPR Therapeutics AG (CRSP)'s stock price history? Over the last year, CRISPR Therapeutics AG's stock price has decreased by %. CRISPR. Analyst Forecast. According to 20 analysts, the average rating for CRSP stock is "Buy." The month stock price forecast is $, which is an increase of. CRISPR Therapeutics AG ; Open $ ; Day Range - ; 52 Week Range - ; Market Cap $B ; Public Float M. View CRISPR Therapeutics AG CRSP stock quote prices, financial information, real-time forecasts, and company news from CNN. CRISPR Therapeutics stock prediction on Wednesday, July, dollars, maximum , minimum CRISPR Therapeutics stock price forecast on Thursday. The current CRISPR Therapeutics AG [CRSP] share price is $ The Score for CRSP is 59, which is 18% above its historic median score of 50, and infers lower. The 17 analysts with month price forecasts for CRSP stock have an average target of , with a low estimate of 30 and a high estimate of The average. Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

The CRISPR Therapeutics AG stock prediction for is currently $ , assuming that CRISPR Therapeutics AG shares will continue growing at the average. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. Based on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $ with a high estimate of $ and a low. 35 analysts offering month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $ This median of share price forecast. According to analysts, CRSP price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range. Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $ The forecasts range from a low of. See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Real time CRISPR Therapeutics (CRSP) stock price quote, stock graph, news & analysis.

The current price of CRSP is USD — it has decreased by % in the past 24 hours. Watch CRISPR Therapeutics AG stock price performance more closely on. Crispr Therapeutics AG reported an EPS of -$ in its last earnings report, missing expectations of -$ Following the earnings report the stock price. CRISPR Therapeutics AG ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. The forecasted annual EBIT of CRISPR Therapeutics AG in is MM. EBIT is an acronym that stands for earnings before interest and taxes. Analysts use. Return on equity is forecast to be % in 3 years. Key information. %. Earnings growth rate.

Cathie Wood on CRISPR \u0026 Genomic Stocks

Find the latest Crispr Therapeutics AG (CRSP) stock forecast, month price target, predictions and analyst recommendations. CRISPR Therapeutics NasdaqGM:CRSP Stock Report ; Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 28 Jun, CRISPR Therapeutics AG ($CRSP) Stock Forecast: Down % Today. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary. CRSP Price Targets Summary. CRISPR Therapeutics AG Wall Street analysts forecast CRSP stock price to rise over the next 12 months. According to Wall Street.

Why CRISPR Therapeutics Could Skyrocket: A Must-Buy Stock for 2024!

how to deal in cryptocurrency | top free crypto wallets

14 15 16 17 18

Copyright 2014-2024 Privice Policy Contacts SiteMap RSS